This month’s healthcare and pharmaceutical coverage highlights how political pressure, regulatory changes, and new technologies are reshaping access to care and influencing public trust. From government action on drug pricing and funding cuts to HIV programs to debates over AI-driven health advice, the industry faces complex challenges at the intersection of innovation, affordability, and safety. […]
